Joni Vuorio

Joni Vuorio

Auto-generated profile, based on publicly available information

Joni Vuorio

Department of Physics, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2020 in Science
Verified
Journal Article
Closed access
PDF file
SWStephan Wilmes
Stephan Wilmes
MHMaximillian Hafer
Maximillian Hafer
JVJoni Vuorio
Joni Vuorio
JTJulie Tucker
Julie Tucker
HWHauke Winkelmann
Hauke Winkelmann
JPJacob Piehler
Jacob Piehler
Activated by interaction: Cytokines trigger immune responses when they bind to their cognate receptors. Class I cytokine receptors rely on the associated Janus kinase 2 (JAK2) to initiate signal transduction. There has been debate over whether activation involves ligand-induced dimerization of these receptors or ligand-induced conformational change of preformed dimers. Wilmes et al. imaged cytokine receptors in the plasma membranes of live human cells by single-molecule fluorescence microscopy and observed ligand-induced dimerization. They found that the JAK2 pseudokinase domains contribute to dimerization and that hyperactive JAK2 mutants promote dimerization, consistent with the model that dimerization triggers activation. Science , this issue p. 643

17 July 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
JVJoni Vuorio
Joni Vuorio
IVIlpo Vattulainen
Ilpo Vattulainen
HMHector Martinez-Seara
Hector Martinez-Seara
Hyaluronan is a polyanionic, megadalton-scale polysaccharide, which initiates cell signaling by interacting with several receptor proteins including CD44 involved in cell-cell interactions and cell adhesion. Previous studies of the CD44 hyaluronan binding domain have identified multiple widespread residues to be responsible for its recognition capacity. In contrast, the X-ray structural characterization of CD44 has revealed a single binding mode associated with interactions that involve just a fraction of these residues. In this study, we show through atomistic molecular dynamics simulations that hyaluronan can bind CD44 with three topographically different binding modes that in unison define an interaction fingerprint, thus providing a plausible explanation for the disagreement between the earlier studies. Our results confirm that the known crystallographic mode is the strongest of the three binding modes. The other two modes represent metastable configurations that are readily available in the initial stages of the binding, and they are also the most frequently observed modes in our unbiased simulations. We further discuss how CD44, fostered by the weaker binding modes, diffuses along HA when attached. This 1D diffusion combined with the constrained relative orientation of the diffusing proteins is likely to influence the aggregation kinetics of CD44. Importantly, CD44 aggregation has been suggested to be a possible mechanism in CD44-mediated signaling. Hyaluronan is a natural sugar polymer in our bodies. Besides acting as a space-filling agent for example in multiple connective tissues, it also functions as a cellular cue in cancer and inflammation. Our tissues sense hyaluronan through receptors—proteins that sit at the surface of cells and grab the molecules they are expected to recognize. Although the knowledge associated with hyaluronan and its receptors is constantly accumulating, the molecular-level insight is largely missing or incomplete due to the lack of techniques able to probe the dynamics of protein–carbohydrate interactions with sufficiently high resolution. In this work, we characterize the binding of hyaluronan to its receptor CD44 with atomistic precision. We achieve this level of precision by employing atomistic molecular dynamics simulations. This computational technique allows one to follow the movement of atoms of a virtual system at scales beyond the resolution of any experimental technique. Our work specifically focuses on the different stages of hyaluronan–CD44 binding, and we observe the process to involve three different binding modes, making it more versatile than previously thought. Our insights, therefore, promote the understanding of the interplay between hyaluronan and HA, thereby fostering development of new drugs or inhibitors to malignancies, such as cancer metastasis.

1 September 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AGAby Grabon
Aby Grabon
AOAdam Orłowski
Adam Orłowski
ATAshutosh Tripathi
Ashutosh Tripathi
JVJoni Vuorio
Joni Vuorio
MJMatti Javanainen
Matti Javanainen
VBVytas A. Bankaitis
Vytas A. Bankaitis
Phosphatidylinositol-transfer proteins (PITPs) regulate phosphoinositide signaling in eukaryotic cells. The defining feature of PITPs is their ability to exchange phosphatidylinositol (PtdIns) molecules between membranes, and this property is central to PITP-mediated regulation of lipid signaling. However, the details of the PITP-mediated lipid exchange cycle remain entirely obscure. Here, all-atom molecular dynamics simulations of the mammalian StART-like PtdIns/phosphatidylcholine (PtdCho) transfer protein PITPα, both on membrane bilayers and in solvated systems, informed downstream biochemical analyses that tested key aspects of the hypotheses generated by the molecular dynamics simulations. These studies provided five key insights into the PITPα lipid exchange cycle: (i) interaction of PITPα with the membrane is spontaneous and mediated by four specific protein substructures; (ii) the ability of PITPα to initiate closure around the PtdCho ligand is accompanied by loss of flexibility of two helix/loop regions, as well as of the C-terminal helix; (iii) the energy barrier of phospholipid extraction from the membrane is lowered by a network of hydrogen bonds between the lipid molecule and PITPα; (iv) the trajectory of PtdIns or PtdCho into and through the lipid-binding pocket is chaperoned by sets of PITPα residues conserved throughout the StART-like PITP family; and (v) conformational transitions in the C-terminal helix have specific functional involvements in PtdIns transfer activity. Taken together, these findings provide the first mechanistic description of key aspects of the PITPα PtdIns/PtdCho exchange cycle and offer a rationale for the high conservation of particular sets of residues across evolutionarily distant members of the metazoan StART-like PITP family.

8 March 2024 in Science Advances
Verified
Journal Article
Closed access
BABobin George Abraham
Bobin George Abraham
THTeemu Haikarainen
Teemu Haikarainen
JVJoni Vuorio
Joni Vuorio
MGMykhailo Girych
Mykhailo Girych
AVAnniina T. Virtanen
Anniina T. Virtanen
Olli SilvennoinenOlli Silvennoinen
Olli Silvennoinen
Janus kinase 2 (JAK2) mediates type I/II cytokine receptor signaling, but JAK2 is also activated by somatic mutations that cause hematological malignancies by mechanisms that are still incompletely understood. Quantitative superresolution microscopy (qSMLM) showed that erythropoietin receptor (EpoR) exists as monomers and dimerizes upon Epo stimulation or through the predominant JAK2 pseudokinase domain mutations (V617F, K539L, and R683S). Crystallographic analysis complemented by kinase activity analysis and atomic-level simulations revealed distinct pseudokinase dimer interfaces and activation mechanisms for the mutants: JAK V617F activity is driven by dimerization, K539L involves both increased receptor dimerization and kinase activity, and R683S prevents autoinhibition and increases catalytic activity and drives JAK2 equilibrium toward activation state through a wild-type dimer interface. Artificial intelligence–guided modeling and simulations revealed that the pseudokinase mutations cause differences in the pathogenic full-length JAK2 dimers, particularly in the FERM-SH2 domains. A detailed molecular understanding of mutation-driven JAK2 hyperactivation may enable novel therapeutic approaches to selectively target pathogenic JAK2 signaling.

12 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJohanna Lilja
Johanna Lilja
JKJasmin Kaivola
Jasmin Kaivola
JCJames Conway
James Conway
JVJoni Vuorio
Joni Vuorio
HPHanna Parkkola
Hanna Parkkola
JIJohanna Ivaska
Johanna Ivaska
The KRAS oncogene drives many common and highly fatal malignancies. These include pancreatic, lung, and colorectal cancer, where various activating KRAS mutations have made the development of KRAS inhibitors difficult. Here we identify the scaffold protein SH3 and multiple ankyrin repeat domain 3 (SHANK3) as a RAS interactor that binds active KRAS, including mutant forms, competes with RAF and limits oncogenic KRAS downstream signalling, maintaining mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) activity at an optimal level. SHANK3 depletion breaches this threshold, triggering MAPK/ERK signalling hyperactivation and MAPK/ERK-dependent cell death in KRAS-mutant cancers. Targeting this vulnerability through RNA interference or nanobody-mediated disruption of the SHANK3–KRAS interaction constrains tumour growth in vivo in female mice. Thus, inhibition of SHANK3–KRAS interaction represents an alternative strategy for selective killing of KRAS-mutant cancer cells through excessive signalling.

25 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JVJoni Vuorio
Joni Vuorio
JŠJana Škerlová
Jana Škerlová
MFMilan Fábry
Milan Fábry
Vaclav VeverkaVaclav Veverka
Vaclav Veverka
IVIlpo Vattulainen
Ilpo Vattulainen
HMHector Martinez-Seara
Hector Martinez-Seara
While DNA encodes protein structure, glycans provide a complementary layer of information to protein function. As a prime example of the significance of glycans, the ability of the cell surface receptor CD44 to bind its ligand, hyaluronan, is modulated by N-glycosylation. However, the details of this modulation remain unclear. Based on atomistic simulations and NMR, we provide evidence that CD44 has multiple distinct binding sites for hyaluronan, and that N-glycosylation modulates their respective roles. We find that non-glycosylated CD44 favors the canonical sub-micromolar binding site, while glycosylated CD44 binds hyaluronan with an entirely different micromolar binding site. Our findings show (for the first time) how glycosylation can alter receptor affinity by shielding specific regions of the host protein, thereby promoting weaker binding modes. The mechanism revealed in this work emphasizes the importance of glycosylation in protein function and poses a challenge for protein structure determination where glycosylation is usually neglected.